Lrrk2 Mutations

Lrrk2 Mutations is a genetic alteration in the leucine-rich repeat kinase 2 gene that constitutes a primary pathogenic mechanism in familial and sporadic forms of Parkinson disease, distinguishing it from other genetic or environmental etiologies by its autosomal dominant inheritance and kinase domain dysfunction.

1.3K

Publications

108.8K

Citations

7.5K

Authors

1.8K

Institutions

Publications per year

2017–2026

578

Authors

7.5K

  1. MJ
    Matthew J. Farrer

    Mayo Clinic in Florida, United States

    78 publications · 11K citations

    49

    h-index

  2. DR
    Dario R. Alessi

    MRC Protein Phosphorylation and Ubiquitylation Unit, United Kingdom

    47 publications · 8K citations

    39

    h-index

  3. MC
    Mark Cookson

    National Institute on Aging, United States

    47 publications · 5.3K citations

    39

    h-index

  4. JA
    Jan Aasly

    Norwegian University of Science and Technology, Norway

    45 publications · 6.1K citations

    35

    h-index

  5. SB
    Susan Bressman

    Mount Sinai Beth Israel, United States

    51 publications · 5.4K citations

    35

    h-index

1–5 of 7.5K

Venues

  1. Human Molecular Genetics

    71 publications · 8.7K citations

    52

    h-index

  2. Movement Disorders

    119 publications · 6.7K citations

    50

    h-index

  3. PLoS ONE

    61 publications · 4.4K citations

    40

    h-index

  4. Neurology

    43 publications · 4.8K citations

    37

    h-index

  5. Parkinsonism & Related Disorders

    57 publications · 2.3K citations

    30

    h-index

1–5